ASN Neuro

ASN Neuro is an open-access peer-reviewed journal published by Taylor & Francis as the official journal of the American Society for Neurochemistry, and its 2025 Journal Impact Factor is 4.4《ASN 神经科学》是由（Taylor & Francis）出版、美国神经化学学会官方刊物的开放获取同行评审期刊，2025 年影响因子为 4.4。

Scope

• The journal covers the breadth of cellular and molecular neuroscience该刊涵盖细胞与分子神经科学的广泛领域。
• It provides investigators with recent advances across the field该刊为研究者呈现本领域的最新进展。
• Topics include glial cell biology and neuroinflammation选题包括胶质细胞生物学与神经炎症。
• It also addresses neurodegeneration and neural repair该刊还涉及神经退行与神经修复。
• The journal welcomes basic, translational and methodological studies该刊欢迎基础、转化与方法学研究。
• It serves the community of cellular and molecular neuroscientists该刊服务细胞与分子神经科学研究者群体。

History

• The journal was conceived by officers of the American Society for Neurochemistry该刊由美国神经化学学会的理事们酝酿创办。
• Its first volume was published in 2009其第一卷于 2009 年出版。
• Anthony Campagnoni served as founding Editor-in-Chief for five years（Anthony Campagnoni）担任创刊主编达五年。
• Monica Carson succeeded him in 2014（Monica Carson）于 2014 年接任其职。
• It is published on an open-access basis and archived in PubMed Central该刊以开放获取方式出版并存档于（PubMed Central）。
• Its 2025 Journal Impact Factor is 4.4, up from 3.7 in 2024该刊 2025 年影响因子为 4.4，高于 2024 年的 3.7。

Editors

• The Editor-in-Chief is Douglas Feinstein of the University of Illinois at Chicago主编为（Douglas Feinstein），任职于伊利诺伊大学芝加哥分校。
• He is a well-known investigator in neuroinflammation他是神经炎症领域的知名研究者。
• The journal is guided by an international editorial board该刊由一支国际化编委会指导。
• It is a member of the Committee on Publication Ethics该刊是出版伦理委员会的成员。
• Submissions are assessed through peer review稿件经同行评审予以评估。
• Article processing charges apply to accepted manuscripts录用稿件需缴纳文章处理费。